By Larry Husten, Contributor The publication in JAMA of the NIH’s Trial To Assess Chelation Therapy (TACT) trial has provoked a fascinating debate in the blogosphere. The vast majority of responsible physicians and healthcare professionals have little interest in chelation therapy per se, but the TACT trial has raised many important questions about the nature of medical evidence. Here’s a brief guide with links to some of the more interesting discussions (let me know if you are aware of other worthwhile discussions): …read more
Source: FULL ARTICLE at Forbes Latest
Tag Archives: TACT
Chelation For Heart Disease: Not What You Have Read
By Peter Lipson, Contributor Continuing what some have hyperbolically called a civil war in medicine, I must call out my colleague Harlan Krumholz. Today on this site, Dr. Krumholz wrote a piece about a recently concluded medical study, known as TACT. The study was meant to examine the possible use of chelation therapy to treat coronary heart disease, the main cause of heart attacks. Our current approach to the disease has been very successful, but we still have a long way to go. Unfortunately, TACT doesn’t take us anywhere. When evaluating medical evidence, the fact that a study has positive results is only important if the results themselves reflect reality. …read more
Source: FULL ARTICLE at Forbes Latest
Controversial NIH Chelation Trial Published In JAMA
By Larry Husten Final results of the troubled NIH-sponsored TACT trial testing chelation therapy for coronary disease have now been published in JAMA. Last November, when the preliminary results were presented at the American Heart Association meeting, the positive finding in favor of chelation therapy surprised many observers, though the investigators and senior AHA representatives expressed considerable caution about the proper interpretation of the results. Full publication of the main results should now allow for a more thorough consideration of the trial. …read more
Source: FULL ARTICLE at Forbes Technology